Functional polymorphisms and methotrexate treatment outcome in recent-onset rheumatoid arthritis

Author： Kooloos Wouter M   Wessels Judith AM   van der Straaten Tahar   Allaart Cornelia F   Huizinga Tom WJ   Guchelaar Henk-Jan  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.11, Iss.2, 2010-02, pp. : 163-175

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

677C>T and 1298A>C MTHFR polymorphisms affect methotrexate treatment outcome in rheumatoid arthritis

By Kurzawski Mateusz   Pawlik Andrzej   Safranow Krzysztof   Herczynska Magdalena   Drozdzik Marek  

Pharmacogenomics, Vol. 8, Iss. 11, 2007-11 ,pp. : 1551-1559

Future Medicine

Access to resources Recommend Favorite

The effect of ESR1 and ESR2 gene polymorphisms on the outcome of rheumatoid arthritis treatment with leflunomide

By Dziedziejko Violetta   Kurzawski Mateusz   Safranow Krzysztof   Chlubek Dariusz   Pawlik Andrzej  

Pharmacogenomics, Vol. 12, Iss. 1, 2011-01 ,pp. : 41-47

Future Medicine

Access to resources Recommend Favorite

Rheumatoid arthritis costly at onset

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 272, 2000-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Sulfasalazine + methotrexate beneficial for rheumatoid arthritis

By  

Inpharma, Vol. 1, Iss. 1577, 2007-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Methotrexate improves survival in rheumatoid arthritis

By  

Inpharma, Vol. 1, Iss. 1333, 2002-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite